Indolent Cutaneous B Cell Lymphomas
1 clinical trials · Condition
◉ Watch Indolent Cutaneous B Cell Lymphomas
| Record | Firm | Date |
|---|---|---|
| Multiple Fields Radiotherapy Versus Intravenous Rituximab in the Treatment of Indolent Cutaneous Lymphomas B-cell With Multiple or Recurrent Lesions (NCT02867553) | CHU de Reims | 2011-10-01 |
Track Indolent Cutaneous B Cell Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.